Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease
Abstract
Treatment of patients with typical cat-scratch disease with oral azithromycin for five days affords significant clinical benefit as measured by total decrease in lymph node volume within the first month of treatment.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
logistic models
adult
female
male
adolescent
middle aged
Child
Prospective Studies
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
anti-bacterial agents / therapeutic use*
azithromycin / therapeutic use*
ultrasonography
pmid:9655532
doi:10.1097/00006454-199806000-00002
j w bass
b c freitas
l n slater
bartonella henselae*
cat-scratch disease / drug therapy*
lymph nodes / diagnostic imaging
Access
Citation
ID:
114260
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114260
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
